The effect of weight loss in obesity and chronic kidney disease

Current Hypertension Reports

Volumn 14, Issue 2, 2012, Pages 170-176

  Morales, Enrique ^a   Praga, Manuel ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hyperfiltration; Kidney disease; Obesity; Proteinuria; RAAS; Renin angiotensin aldosterone system; Weight loss

Indexed keywords

LEPTIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ALBUMINURIA; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA; EXERCISE; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; LOW CALORY DIET; OBESITY; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; WEIGHT REDUCTION;

ALBUMINURIA; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LIFE STYLE; OBESITY; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; SPAIN; WEIGHT LOSS; WORLD HEALTH;

EID: 84861102007     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0247-x     Document Type: Article

References (51)

1. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: A complication of massive obesity. Ann Intern Med. 1974;81:440-7.
2. Verani RR. Obesity-related focal segmental glomerulosclerosis: pathological features of the lesions and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis. 1992;20:629-34. (Pubitemid 23031716)
3. Kambham N, Markowitz G, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498-509. (Pubitemid 32281241)
4. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844-50. (Pubitemid 38543772)
5. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-9. (Pubitemid 29504045)
6. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21-8. (Pubitemid 46780716)
7. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871-80. (Pubitemid 41505461)
8. Munkhaugen J, Ludersen S, Wideroe TE, Hallan S. Prehypertension, obesity, and risk of kidney disease: 20 year follow-up of the HUNT I study in Norway. Am J Kidney Dis. 2009;54:638-646.
9. Praga M. Obesity: a neglected culprit in renal disease. Nephrol Dial Transplant. 2002;17:1157-9. (Pubitemid 34812055)
10. Kasiske BL, Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol. 1985;5:45-50. (Pubitemid 15195137)
11. Praga M, Hernández E, Morales E, et al. Clinical features and long term outcome of obesity-related focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001;16:1790-8. (Pubitemid 32821410)
12. Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr. 2001;138:481-5. (Pubitemid 32319719)
13. Praga M, Morales E, Herrero JC, et al. Disminución de masa renal funcionante y proteinuria. Nefrología. 1998;18:17-22. (Pubitemid 28292283)
14. Praga M, Bornstein B, Andrés A, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis. 1991;17:330-8.
15. PragaM, Morales E, Herrero JC, et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis. 1999;33:52-8. (Pubitemid 29031208)
16. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994;46:1223-41. (Pubitemid 24319965)
17. Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens. 2006;15:481-6.
18. Afshinnia F, Wilt TJ, Duval S et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant. 2010;25:1173-1183.
19. Navaneethan SD, Yehnert H, Moustarah F et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:1565-1574.
20. Vasquez B, Flock EV, Savage PV, et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia. 1984;26:127-33. (Pubitemid 14190669)
21. Solerte SB, Fioravanti M, Schifino N, et al. Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes. 1989;13:203-11. (Pubitemid 19144696)
22. Saiki A, Nagayama D, Ohhira M, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obesity (Lond). 2005;29:1115-20. (Pubitemid 41192220)
23. Praga M, Hernández E, Andres A, et al. Effects of body-weight loss and captopril treatment on obesity-related proteinuria. Nephron. 1995;70:35-41.
24. Morales E, Valero MA, León M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003;41:319-27. (Pubitemid 36152449)
25. Friedman AN, Yu Z, Juliar BE, et al. Independent influence of dietary protein in markers of kidney function and disease in obesity. Kidney Int. 2010;78:693-697.
26. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288:2793-6. (Pubitemid 35425059)
27. Soto FC, Higa-Sansone G, Copley JB, et al. Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass. Obes Surg. 2005;15:137-40. (Pubitemid 40203840)
28. Izzedine H, Coupaye M, Reach I, Deray G. Gastric bypass and resolution of proteinuria in obese diabetic patient. Diabetes Med. 2005;22:1761-2. (Pubitemid 43046481)
29. Palomar R, Fernández-Fresnedo G, Dominguez-Diez A, et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg. 2005;15:794-8. (Pubitemid 40904868)
30. Agrawal V, Khan I, Rai B, et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol. 2008;70:194-202.
31. Yanovski SZ, Yanosvski JA. Obesity. N Eng J Med. 2002;346:591-602. (Pubitemid 34438821)
32. Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353:2111-20. (Pubitemid 41653103)
33. Despres JP, Golay A, Sjöström L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005;353:2121-34. (Pubitemid 41653104)
34. Wolf G, Hamann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int. 1999;56:860-72. (Pubitemid 29411714)
35. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480-6. (Pubitemid 36687049)
36. Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the reninangiotensin- aldosterone system. Hypertension. 2005;45:356-62. (Pubitemid 40315803)
37. Praga M, Morales E. Obesity-related renal damage: changing diet to avoid progression. Kidney Int. 2010;78:633-5.
38. Iglesias P, Díez JJ. Adipose tissue in renal disease: clinical significance and prognostic implications. Nephrol Dial Transplant. 2010;25:2066-2077.
39. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease; the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010;21:406-412.
40. Hall JE, Brandy MW, Henegar JR, Shek EW. Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol. 1998;25:58-64. (Pubitemid 28064510)
41. Chagnac A, Weinstein T, Korzets A. et al: Glomerular hemodynamics in severe obesity. Am J Physiol. 2000;278:F817-22. (Pubitemid 30351084)
42. Bickel CA, Verbalis JG, Knepper MA, Ecelbarger CA. Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats. Am J Physiol Renal Physiol. 2001;281:F639-648.
43. González E, Gutierrez E, Morales E, et al. Factors influencing the progresión of renal damage in patients with unilateral renal agenesis and remmant kidney. Kidney Int. 2005;68:263-70. (Pubitemid 43181384)
44. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73-87. (Pubitemid 32661190)
45. Hall JE. The kidney, hypertension and obesity. Hypertension. 2003;41:625-33.
46. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004;15:2816-27. (Pubitemid 41103390)
47. Hunley TE, Ma LJ, Kon V. Scope and mechanisms of obesityrelated renal disease. Curr Opin Nephrol Hypertens. 2010;19:227-234.
48. De Paula RB, Da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension. 2004;43:41-7. (Pubitemid 38031909)
49. Bomback A, Klemmer PJ. Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-related kidney disease: a narrative review. Am J Nephrol. 2009;30:140-146.
50. Hostetter TH, Ibrahim M. Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol. 2003;14:2395-401. (Pubitemid 37052388)
51. Morales E, Huerta A, Gutierrez E, et al. The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? Nefrologia. 2009;29:421-9.